文献速递泌尿生殖与妇科肿瘤放疗

基于诊断时肿瘤乏氧与近距离放疗时体积反应的宫颈癌MRI引导动态风险评估

MRI-guided dynamic risk assessment in cervical cancer based on tumor hypoxia at diagnosis and volume response at brachytherapy.
PubMed 文献 · Radiother Oncol · 2024-03-29

研究纳入93例局部晚期宫颈癌患者,利用治疗前DCE-和DW-MR图像计算乏氧分数(HFpre),并结合近距离放疗时T2W-MR评估的体积退缩进行风险分类。HFpre是DFS最强预测因子,HFpre与体积退缩联合较单用HFpre与DFS关联更强,复发患者被以100%准确率分入中危或高危组。ADC与体积退缩整合得到的功能性退缩与HFpre相关性更强,有望成为新的肿瘤反应参数。

要点

  • 治疗前乏氧分数(HFpre)是局部晚期宫颈癌无病生存的最强预测因子。
  • HFpre联合近距离放疗时体积退缩较单用HFpre与无病生存关联更强。
  • 复发患者被以100%准确率分入中危或高危组。

核心结论

  • 治疗前乏氧与近距离放疗时体积退缩联合可改善局部晚期宫颈癌患者的风险分类。
  • ADC与体积退缩整合得到的功能性退缩作为新的肿瘤反应参数显示出前景。

研究设计与样本

  • 收集93例局部晚期宫颈癌患者治疗前T2W-、DCE-和DW-MR图像,以及近距离放疗时T2W-MR图像和64例患者的DW-MR图像。
  • 治疗前乏氧分数(HFpre)由DCE-和DW-MR图像采用基于消耗与供应的乏氧(CSH)成像方法确定。
  • 近距离放疗时体积退缩由T2W-MR图像评估并与HFpre联合。
  • 17例近距离放疗时DW-MR图像质量合格的患者计算了反映肿瘤细胞密度的表观扩散系数(ADC)。
  • ADC在治疗中的变化与体积退缩联合得到功能性退缩,作为探索性反应指标;终点为无病生存(DFS)。

主要发现

  • HFpre是DFS最强预测因子,体积退缩也与结局显著相关。
  • HFpre与体积退缩联合较单用HFpre与DFS关联更强。
  • 复发患者被以100%准确率分入中危或高危组。
  • 功能性退缩与HFpre的相关性强于体积退缩。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND PURPOSE: Improvements in treatment outcome for patients with locally advanced cervical cancer (LACC) require a better classification of patients according to their risk of recurrence. We investigated whether an imaging-based approach, combining pretreatment hypoxia and tumor response during therapy, could improve risk classification. MATERIAL AND METHODS: Ninety-three LACC patients with T2-weigthed (T2W)-, dynamic contrast enhanced (DCE)- and diffusion weighted (DW)-magnetic resonance (MR) images acquired before treatment, and T2W- and, for 64 patients, DW-MR images, acquired at brachytherapy, were collected. Pretreatment hypoxic fraction (HFpre) was determined from DCE- and DW-MR images using the consumption and supply-based hypoxia (CSH)-imaging method. Volume regression at brachytherapy was assessed from T2W-MR images and combined with HFpre. In 17 patients with adequate DW-MR images at brachytherapy, the apparent diffusion coefficient (ADC), reflecting tumor cell density, was calculated. Change in ADC during therapy was combined with volume regression yielding functional regression as explorative response measure. Endpoint was disease free survival (DFS). RESULTS: HFpre was the strongest predictor of DFS, but a significant correlation with outcome was found also for volume regression. The combination of HFpre and volume regression showed a stronger association with DFS than HFpre alone. Patients with disease recurrence were selected to either the intermediate- or high-risk group with a 100 % accuracy. Functional regression showed a stronger correlation to HFpre than volume regression. CONCLUSION: The combination of pretreatment hypoxia and volume regression at brachytherapy improved patient risk classification. Integration of ADC with volume regression showed promise as a new tumor response parameter.

来源:Radiother Oncol,查看原文。版权归原作者所有。

引用

  1. Skipar K, Hompland T, Lund KV, et al. MRI-guided dynamic risk assessment in cervical cancer based on tumor hypoxia at diagnosis and volume response at brachytherapy. Radiother Oncol. 2024. PMID: 38556173. doi:10.1016/j.radonc.2024.110263

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。